1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6F9D1D76351707BF70025890B004D8E87
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-evaluating-enhancing-patient-medication-adherence?opendocument
18
19opendocument
2044.210.149.218
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




» Products & Services » » Patient Focused Services » Patient Insights

White Paper: Evaluating and Enhancing Patient Medication Adherence

Whitepaper Image

ID: BEB-95


Pages/Slides: 7


Published: 2022


Delivery Format: PDF


 

License Options:


Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
In today’s value-based healthcare system, failure to adhere to medication is one of the primary reasons patients don’t achieve optimal health outcomes. Industry estimates indicate the cost of medication nonadherence to be $637 billion in potential sales annually. The attention on adherence more often focuses on the added medical expenditures to the healthcare system - estimated at $300 billion annually - and the cost in health outcomes for patients.

Specialty pharmacies, hub services, pay services, patient support agencies – all play a major role in facilitating a continuum of care for patients dealing with complex disease states and accompanying challenging therapies. The growth of these services has led to multiple patient touchpoints but without a commensurate industry-wide increase in adherence rates. While various factors contribute to the stagnation in adherence rates, it is important for pharma manufacturers to isolate the main concerns and improve patient medication adherence.

Best Practices, LLC conducted benchmarking research – spotlighted in this white paper – to deliver industry benchmarks around patient medication adherence rates. The research highlights the main challenges faced by pharma manufacturers in improving adherence and ways to aid patients overcome adherence barriers. It also provides benchmarks for core performance metrics such as Fill Rates, Time to Fill, and Reimbursement Rates, as well as complex indicators like Adherence, Persistence, and Compliance Rates.

The findings and benchmarks examined in this white paper include:

  • Tracking Basic and Complex Patient Medication Adherence Metrics
  • Average Adherence Rates and Zone of Competitive Effectiveness
  • Effective Data Sources for Adherence Metrics
  • Oral Adherence Industry Case Studies
Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research; Communications


Companies Profiled:
Pharma; Biotech; Medical Device Companies